Safety and efficacy of sorafenib in elderly patients treated in the North ... - UroToday Print
UroTodayIn this retrospective analysis of the Advanced Renal Cell Carcinoma Sorafenib (ARCCS) program in North America, we compared the safety and efficacy of

... read more